FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23449 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Subcutaneous injection NOS Injection into subcutaneous tissue (procedure)
Subcutaneous injection for local action Injection into subcutaneous tissue (procedure)
Subcutaneous injection for local action NEC Injection into subcutaneous tissue (procedure)
Subcutaneous injection of Pneumovax II Subcutaneous injection of pneumococcal vaccine
Subcutaneous injection of Pneumovax II Subcutaneous injection of pneumococcal vaccine
Subcutaneous tissue of anterior surface of leg Subcutaneous tissue structure of anterior surface of lower leg
Subcutaneous tissue of gluteal fold of lower extremity Subcutaneous tissue structure of gluteal fold
Subdural hemorrhage following injury with open intracranial wound and unspecified state of consciousness Traumatic intracranial subdural haemorrhage following open wound of head
Subdural hemorrhage following injury without open intracranial wound with unspecified state of consciousness Closed traumatic subdural intracranial hemorrhage
Subdural tap through fontanel, infant, initial Subdural tap through fontanel
Subfamily Acinonychinae Subfamily Felinae (organism)
Subfamily Ailurinae Family Ailuridae (organism)
Subfamily Coronavirinae Subfamily Orthocoronavirinae (organism)
Subfamily Cryptoproctinae Subfamily Euplerinae (organism)
Subfamily Ctenomyinae Tribe Ctenomyini (organism)
Subfamily Herpestinae Family Herpestidae (organism)
Subfamily Hyaeninae Family Hyaenidae (organism)
Subfamily Lentivirinae (organism) Genus Lentivirus (organism)
Subfamily Nandiniinae Family Nandiniidae (organism)
Subfamily Protelinae Family Hyaenidae (organism)
Subfamily Rynchopinae Family Laridae (organism)
Subfamily Spumavirinae Genus Spumavirus (organism)
Subfamily Taxidinae Subfamily Mustelinae (organism)
Subfamily Ursinae Family Ursidae (organism)
Subfamily boinae Boa
Subglottis TNM finding American Joint Committee on Cancer allowable value
Submandibular gland X-ray Plain X-ray of submandibular salivary gland (procedure)
Submental flap Submental artery flap
Submucosal injection of contrast media for radiography Injection of radiocontrast material
Suborder cyclorrhapha - superfamily muscoidea Suborder Brachycera (organism)
Suborder onchopalpida Superorder Parasitiformes (organism)
Suborder sauria - lizard Lizard
Suborder tylopoda Family Camelidae (organism)
Subsequent stage of staged operation NOC Subsequent stage of staged operation
Subsidiary classification of operations NOS Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions.
Substance NOS - toxic effect Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health.
Substance NOS - toxic effect Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health.
Substance of abuse Substance
Substance with penicillin structure and antibacterial mechanism of action Penicillin
Substance-induced sleep disorder Drug-induced sleep disorder (disorder)
Subtilisin Subtilisin
Subungual glomus tumor Subungual benign glomus tumor (disorder)
Succinylated gelatin 4% infusion solution 1 L bottle Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug)
Succinylated gelatin 4% infusion solution 500 mL bottle Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug)
Succinylated gelatin 4% infusion solution bottle Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug)
Succinylcholine extract Product containing succinylcholine (medicinal product)
Sucralfate 1mg tablet Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug)
Sucrose 30% eye drops Product containing precisely sucrose 300 milligram/1 milliliter conventional release eye solution (clinical drug)
Sue Spence assessment Spence Children's Anxiety Scale
Sufentanil citrate 50mcg/mL injection solution ampule Sufentanil only product
Suffocation by constriction Asphyxiation by sustained compression of chest
Suicide NOS Suicide
Suicide NOS Suicide
Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream
Sulfabenzamide+sulfacetamide+sulfathiazole 3.7%/2.86%/3.42% vaginal cream Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream
Sulfacetamide 10% eye ointment Sulfacetamide sodium 100 mg/g eye ointment
Sulfacetamide 10% lotion Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)
Sulfacetamide 2.5% eye ointment Sulfacetamide sodium 25 mg/g eye ointment
Sulfacetamide 20% eye drops Sulfacetamide sodium 200 mg/mL eye solution
Sulfacetamide 30% eye drops Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug)
Sulfacetamide 6% eye ointment Sulfacetamide sodium 60 mg/g eye ointment
Sulfacetamide sodium 10% eye drops Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Sulfacetamide sodium 10% ointment Sulfacetamide sodium 100 mg/g eye ointment
Sulfadiazine 1g/4mL injection Sulfadiazine 250 mg/mL solution for injection
Sulfamethoxpyridazine Sulfamethoxypyridazine (substance)
Sulfasalazine 3g/100mL retention enema Sulfasalazine 30 mg/mL rectal suspension
Sulfisoxazole 500mg/5 ml suspension Sulfafurazole 100 mg/mL oral suspension
Sulfisoxazole acetyl 0.5g/5mL suspension Sulfafurazole 100 mg/mL oral suspension
Sulfisoxazole acetyl 500mg/5mL suspension Sulfafurazole 100 mg/mL oral suspension
Sulfonamide overdose Sulfonamide antibacterial overdose
Sulfonamide-sulfonamide combination Product containing sulfonamide (product)
Sulfotransferase Sulfotransferase
Sulfur hexafluoride 40microliter powder for injection solution Product containing only sulfur hexafluoride (medicinal product)
Sulfur hexafluoride 40microliter powder for injection solution + solvent Product containing only sulfur hexafluoride (medicinal product)
Sulfuric ester hydrolase Sulfatase
Sulfurtransferase Sulfurtransferase
Sulphacetamide 30% eye drops Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug)
Sulphur hexafluoride 40microlitres injection (pdr for recon)+solvent Product containing only sulfur hexafluoride (medicinal product)
Sumatriptan 10mg nasal spray Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 12mg/mL injection solution 0.5mL prefilled syringe Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan 20mg nasal spray Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 4mg injection solution prefilled cartridge Product containing only sumatriptan in parenteral dose form (medicinal product form)
Sumatriptan 5mg nasal spray Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 6mg injection solution prefilled cartridge Product containing only sumatriptan in parenteral dose form (medicinal product form)
Sumatriptan 6mg/0.5mL injection Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan 6mg/0.5mL injection refill Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 6mg/0.5mL injection Sumatriptan succinate 12 mg/mL solution for injection
Summitt syndrome A rare syndromic craniosynostosis with variable phenotypic expression characterized by craniosynostosis, intellectual disability, distinctive facies, abnormalities of the fingers and toes (brachydactyly, polydactyly and syndactyly), short stature, congenital heart disease, skeletal defects, obesity, genital abnormalities and umbilical hernia.
Superfamily Syngamoidea Family Syngamidae (organism)
Superfamily scolioidea Superfamily Vespoidea (organism)
Superfamily vespoidea Family Vespidae (organism)
Superficial foreign body of abdominal wall without major open wound AND without infection Foreign body in skin of abdomen
Superficial foreign body of abdominal wall without major open wound but with infection Foreign body in skin of abdomen with infection (disorder)
Superficial foreign body of ankle without major open wound AND without infection Foreign body in skin of ankle
Superficial foreign body of ankle without major open wound but with infection Foreign body in skin of ankle with infection
Superficial foreign body of anus without major open wound AND without infection Superficial foreign body in anus
Superficial foreign body of anus without major open wound but with infection Superficial foreign body of anus with infection
Superficial foreign body of axilla without major open wound AND without infection Foreign body in skin of axilla (disorder)
Superficial foreign body of axilla without major open wound but with infection Foreign body in skin of axilla with infection (disorder)

Start Previous Page 202 of 235 Next End


Reference Sets

Reference set descriptor

Back to Start